Tag: FDA
-
Study Testing Wearables Data for Covid-19 Clues
A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users.
-
Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines.
-
NIH Nixes Convalescent Plasma Covid-19 Therapy
An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections.
-
Late-Stage Covid-19 Vaccine Trial Underway in U.S.
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes.
-
Food Allergy Biotech Acquired for $2.6B
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion.
-
NIH Issues Contracts for Faster Covid-19 Diagnostics
National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays.
-
NIH Expands Covid-19 Test Technology Challenge
National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster.
-
Immune Responses Shown in Covid-19 Nasal Vaccine
An experimental vaccine to prevent Covid-19 infections, given as a nasal spray, produces immune responses in tests with lab mice.
-
BARDA to Buy $2B in Covid-19 Vaccines, Therapies
The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials.
-
FDA Halts Off-the-Shelf Engineered T-Cell Trial
A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died.